SCN-RDMM Catalyst Grant

SCN-RDMM Catalyst Grant

SCN-RDMM Catalyst Grant

Applications are now closed

The Stem Cell Network and the Rare Diseases: Models & Mechanisms (RDMM) Network are thrilled to renew their collaboration in support of the RDMM Catalyst Grant program. This initiative supports cutting-edge research by linking researchers with expertise in genes, pathways, or cellular systems with clinician-scientists working on new or understudied human rare disease genes.

To qualify, potential applicants must first register with the RDMM national registry. RDMM’s Scientific Advisory Committee will then use the database to identify and connect researchers with clinician-scientists who have discovered a new rare disease gene. Eligible database registrants will be invited to apply for a $30,000 RDMM Catalyst Grant. Additionally, researchers using stem cells or organoids to model a rare disease gene variant may qualify for an SCN award supplement of $20,000. 

For details, visit RDMM’s website or contact researchSCN@stemcellnetwork.ca or Philip Hieter (hieter@msl.ubc.ca).

Previous Awardees

  • Dr. Roman Krawetz, University of Calgary
    Project Title: Using human pluripotent stem cells as a model to investigate the role of FOS and patient-specific mutations of this gene in osteoclastogenesis
    Award Term: March 1, 2024 – February 28, 2025
  • Dr. Yun Li, The Hospital for Sick Children
    Project Title: Investigating the neural pathophysiology and treatment strategy for PIK3CA-related overgrowth syndrome (PROS)
    Award Term: December 1, 2024 – November 30, 2025
  • Dr. Ian Weaver, Dalhousie University
    Project Title:Characterization of ATRX binding and genome-wide localization in Setbp1 genetic variants relevant to SETBP1-HD
    Award Term: January 13, 2025 – January 12, 2026
Learn More